ArticlePloS one2015

Endocytotic uptake of zoledronic acid by tubular cells may explain its renal effects in cancer patients receiving high doses of the compound.

Anja Verhulst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.